Civil Society From 17 European Countries File Patent Opposition On Key Hepatitis C Drug

Public health group Médecins Sans Frontières (MSF) announced today that it has joined civil society organisations from 17 countries in Europe in filing a patent challenge at the European Patent Office to Gilead’s patent on sofosbuvir, an important treatment for hepatitis C.
Author: Kim Treanor

WordPress Video Lightbox